Oxidative stress in obstructive nephropathy

International Journal of Experimental Pathology

Volumn 92, Issue 3, 2011, Pages 202-210

  Dendooven, Amélie ^a   Ishola Jr, David A ^a   Nguyen, Tri Q ^a   Van der Giezen, Dionne M ^a   Kok, Robbert Jan ^b   Goldschmeding, Roel ^a   Joles, Jaap A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

NADPH oxidase; Oxidative stress; Renal disease; Unilateral ureteric obstruction

Indexed keywords

1 [5 CHLORO 2 [2 [4 (4 FLUOROBENZYL) 2 METHYL 1 PIPERAZINYL] 2 OXOETHOXY]PHENYL]UREA; 1 [7 (4 FLUOROPHENYL) 1,2,3,4 TETRAHYDRO 8 (4 PYRIDYL)PYRAZOLO[5,1 C][1,2,4]TRIAZIN 2 YL] 2 PHENYLETHANEDIONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BONE MORPHOGENETIC PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LY 364947; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NPC 31169; PROTEIN SERINE THREONINE KINASE INHIBITOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

GENE THERAPY; HISTOPATHOLOGY; HUMAN; INFLAMMATION; KIDNEY FIBROSIS; NONHUMAN; OBSTRUCTIVE UROPATHY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

ACETOPHENONES; ANIMALS; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; FIBROSIS; KIDNEY; MICE; NADPH OXIDASE; OXIDATIVE STRESS; URETERAL OBSTRUCTION;

EID: 79955956606     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2010.00730.x     Document Type: Review

References (132)

1. Adler S., Huang H., Wolin M.S., Kaminski P.M. (2004) Oxidant stress leads to impaired regulation of renal cortical oxygen consumption by nitric oxide in the aging kidney. J. Am. Soc. Nephrol. 15, 52-60.
2. Akin M., Demirbilek S., Selma A. et al. (2007) Attenuation of ureteral obstruction-induced renal injury by polyenylphosphatidylcholine. Int. J. Urol. 14, 350-356.
3. Anders H., Vielhauer V., Frink M. et al. (2002) A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. J. Clin. Invest. 109, 251-259.
4. Asaba K., Tojo A., Onozato M. et al. (2005) Effects of NADPH oxidase inhibitor in diabetic nephropathy. Kidney Int. 67, 1890-1898.
5. Babior B.M. (1999) NADPH oxidase: an update. Blood 93, 1464-1476.
6. Babior B.M. (2004) NADPH oxidase. Curr. Opin. Immunol. 16, 42-47.
7. Bapat S., Post J.A., Braam B. et al. (2002) Visualizing tubular lipid peroxidation in intact renal tissue in hypertensive rats. J. Am. Soc. Nephrol. 13, 2990-2996.
8. Bascands J.L., Schanstra J.P. (2005) Obstructive nephropathy: insights from genetically engineered animals. Kidney Int. 68, 925-937.
9. Beltowski J., Wójcicka G., Jamroz-Wiśniewska A., Borkowska E., Marciniak A. (2005) Antioxidant treatment normalizes nitric oxide production, renal sodium handling and blood pressure in experimental hyperleptinemia. Life Sci. 77, 1855-1868.
10. Blitz I.L., Cho K.W. (2009) Finding partners: how BMPs select their targets. Dev. Dyn. 238, 1321-1331.
11. Block K., Eid A., Griendling K.K., Lee D.Y., Wittrant Y., Gorin Y. (2008) Nox4 NAD(P)H oxidase mediates Src-dependent tyrosine phosphorylation of PDK-1 in response to angiotensin II: role in mesangial cell hypertrophy and fibronectin expression. J. Biol. Chem. 283, 24061-24076.
12. Bondi C.D., Manickam N., Lee D.Y. et al. (2010) NAD(P)H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts. J. Am. Soc. Nephrol. 21, 93-102.
13. Brownlee M. (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414, 813-820.
14. Brownlee M. (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54, 1615-1625.
15. Cachat F., Lange-Sperandio B., Chang A.Y. et al. (2003) Ureteral obstruction in neonatal mice elicits segment-specific tubular cell responses leading to nephron loss. Kidney Int. 63, 564-575.
16. Chabrashvili T., Tojo A., Onozato M. et al. (2002) Expression and cellular localization of classic NADPH oxidase subunits in the spontaneously hypertensive rat kidney. Hypertension 39, 269-274.
17. Chen J.X., Stinnett A. (2008) Critical role of the NADPH oxidase subunit p47phox on vascular TLR expression and neointimal lesion formation in high-fat diet-induced obesity. Lab. Invest. 88, 1316-1328.
18. Chevalier R.L. (1990) Counterbalance in functional adaptation to ureteral obstruction during development. Pediatr. Nephrol. 4, 442-444.
19. Chevalier R.L. (2004) Promise for gene therapy in obstructive nephropathy. Kidney Int. 66, 1709-1710.
20. Chevalier R.L., Forbes M.S., Thornhill B.A. (2009) Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int. 75, 1145-1152.
21. Chirino Y.I., Sánchez-González D.J., Martínez-Martínez C.M., Cruz C., Pedraza-Chaverri J. (2008) Protective effects of apocynin against cisplatin-induced oxidative stress and nephrotoxicity. Toxicology 245, 18-23.
22. Chung A.C., Huang X., Zhou L., Heuchel R., Lai K.N., Lan H. (2009) Disruption of the Smad7 gene promotes renal fibrosis and inflammation in unilateral ureteral obstruction (UUO) in mice. Nephrol. Dial. Transplant. 24, 1443-1454.
23. Costa C.A., Amaral T.A., Carvalho L.C. et al. (2009) Antioxidant treatment with tempol and apocynin prevents endothelial dysfunction and development of renovascular hypertension. Am. J. Hypertens. 22, 1242-1249.
24. Djamali A., Vidyasagar A., Adulla M., Hullett D., Reese S. (2009) Nox-2 is a modulator of fibrogenesis in kidney allografts. Am. J. Transplant. 9, 74-82.
25. Esteban V., Lorenzo O., Ruperez M. et al. (2004) Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction. J. Am. Soc. Nephrol. 15, 1514-1529.
26. Fan Y.Y., Nishiyama A., Fujisawa Y. et al. (2009) Contribution of chymase-dependent angiotensin II formation to the progression of tubulointerstitial fibrosis in obstructed kidneys in hamsters. J. Pharmacol. Sci. 111, 82-90.
27. Fern R.J., Yesko C.M., Thornhill B.A., Kim H.S., Smithies O., Chevalier R.L. (1999) Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice. J. Clin. Invest. 103, 39-46.
28. Frokiaer J. (2005) Pharmacologic intervention in urinary tract obstruction-is it possible? Kidney Int. 68, 894-895.
29. Fujii M., Inoguchi T., Maeda Y. et al. (2007) Pitavastatin ameliorates albuminuria and renal mesangial expansion by downregulating NOX4 in db/db mice. Kidney Int. 72, 473-480.
30. Fukasawa H., Yamamoto T., Togawa A. et al. (2004) Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice. Proc. Natl Acad. Sci. USA 101, 8687-8692.
31. Gaertner S.A., Janssen U., Ostendorf T., Koch K.M., Floege J., Gwinner W. (2002) Glomerular oxidative and antioxidative systems in experimental mesangioproliferative glomerulonephritis. J. Am. Soc. Nephrol. 13, 2930-2937.
32. Gao X., Mae H., Ayabe N. et al. (2002) Hepatocyte growth factor gene therapy retards the progression of chronic obstructive nephropathy. Kidney Int. 62, 1238-1248.
33. Geiszt M., Kopp J.B., Várnai P., Leto T.L. (2000) Identification of renox, an NAD(P)H oxidase in kidney. Proc. Natl Acad. Sci. USA 97, 8010-8014.
34. Grgic I., Kiss E., Kaistha B.P. et al. (2009) Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels. Proc. Natl Acad. Sci. USA 106, 14518-14523.
35. Griendling K.K., Harrison D.G. (2001) Out, damned dot: studies of the NADPH oxidase in atherosclerosis. J. Clin. Invest. 108, 1423-1424.
36. Griendling K.K., Sorescu D., Ushio-Fukai M. (2000) NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 86, 494-501.
37. Gwinner W., Deters-Evers U., Brandes R.P. et al. (1998) Antioxidant-oxidant balance in the glomerulus and proximal tubule of the rat kidney. The Journal of Physiology 509, 599-606.
38. Haque M.Z., Majid D.S. (2008) Reduced renal responses to nitric oxide synthase inhibition in mice lacking the gene for gp91phox subunit of NAD(P)H oxidase. Am. J. Physiol. Renal Physiol. 295, F758-F764.
39. Hart B.A., Elferink J.G., Nibbering P.H. (1992) Effect of apocynin on the induction of ulcerative lesions in rat skin injected with tubercle bacteria. Int. J. Immunopharmacol. 14, 953-961.
40. Henderson N.C., Mackinnon A.C., Farnworth S.L. et al. (2008) Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. Am. J. Pathol. 172, 288-298.
41. Hruska K., Guo G., Wozniak M. et al. (2000) Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. Am. J. Physiol. Renal Physiol. 279, F130-F143.
42. Hu L., Zhang Y., Lim P.S. et al. (2006) Apocynin but not L-arginine prevents and reverses dexamethasone-induced hypertension in the rat. Am. J. Hypertens. 19, 413-418.
43. Iliescu R., Cucchiarelli V.E., Yanes L.L., Iles J.W., Reckelhoff J.F. (2007) Impact of androgen-induced oxidative stress on hypertension in male SHR. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292, R731-R735.
44. Inazaki K., Kanamaru Y., Kojima Y. et al. (2004) Smad3 deficiency attenuates renal fibrosis, inflammation, and apoptosis after unilateral ureteral obstruction. Kidney Int. 66, 597-604.
45. Ito K., Chen J., Khodadadian J.J. et al. (2004) Liposome-mediated transfer of nitric oxide synthase gene improves renal function in ureteral obstruction in rats. Kidney Int. 66, 1365-1375.
46. Ito K., Chen J., Seshan S.V. et al. (2005) Dietary arginine supplementation attenuates renal damage after relief of unilateral ureteral obstruction in rats. Kidney Int. 68, 515-528.
47. Jackson S.H., Gallin J.I., Holland S.M. (1995) The p47phox mouse knock-out model of chronic granulomatous disease. J. Exp. Med. 182, 751-758.
48. Jin L., Beswick R.A., Yamamoto T. et al. (2006) Increased reactive oxygen species contributes to kidney injury in mineralocorticoid hypertensive rats. J. Physiol. Pharmacol. 57, 343-357.
49. Kamijo-Ikemori A., Sugaya T., Obama A. et al. (2006) Liver-type fatty acid-binding protein attenuates renal injury induced by unilateral ureteral obstruction. Am. J. Pathol. 169, 1107-1117.
50. Kaneto H., Morrissey J., McCracken R. et al. (1994) Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney. Kidney Int. 45, 1637-1647.
51. Kawabata M., Imamura T., Miyazono K. (1998) Signal transduction by bone morphogenetic proteins. Cytokine Growth Factor Rev. 9, 49-61.
52. Kawada N., Moriyama T., Ando A. et al. (1999) Increased oxidative stress in mouse kidneys with unilateral ureteral obstruction. Kidney Int. 56, 1004-1013.
53. Kinter M., Wolstenholme J.T., Thornhill B.A., Newton E.A., McCormick M.L., Chevalier R.L. (1999) Unilateral ureteral obstruction impairs renal antioxidant enzyme activation during sodium depletion. Kidney Int. 55, 1327-1334.
54. Klahr S. (2003) The bone morphogenetic proteins (BMPs). Their role in renal fibrosis and renal function. J. Nephrol. 16, 179-185.
55. Klahr S., Morrissey J. (2002) Obstructive nephropathy and renal fibrosis. Am. J. Physiol. Renal Physiol. 283, F861-F875.
56. Klahr S., Morrissey J. (2003) Obstructive nephropathy and renal fibrosis: The role of bone morphogenic protein-7 and hepatocyte growth factor. Kidney Int. Suppl. 87, S105-S112.
57. LaSpina M., Tripathi S., Gatto L.A., Bruch D., Maier K.G., Kittur D.S. (2008) An interleukin-6-neutralizing antibody prevents cyclosporine-induced nephrotoxicity in mice. J. Surg. Res. 148, 121-125.
58. Le Meur Y., Tesch G., Hill P.A. et al. (2002) Macrophage accumulation at a site of renal inflammation is dependent on the M-CSF/c-fms pathway. J. Leukoc. Biol. 72, 530-537.
59. Leask A. (2008) Targeting the TGFbeta, endothelin-1 and CCN2 axis to combat fibrosis in scleroderma. Cell. Signal. 20, 1409-1414.
60. Lenda D.M., Kikawada E., Stanley E.R., Kelley V.R. (2003) Reduced macrophage recruitment, proliferation, and activation in colony-stimulating factor-1-deficient mice results in decreased tubular apoptosis during renal inflammation. J. Immunol. 170, 3254-3262.
61. Li Y., Trush M.A. (1998) Diphenyleneiodonium, an NAD(P)H oxidase inhibitor, also potently inhibits mitochondrial reactive oxygen species production. Biochem. Biophys. Res. Commun. 253, 295-299.
62. Li C.Y., Deng Y.L., Sun B.H. (2009) Effects of apocynin and losartan treatment on renal oxidative stress in a rat model of calcium oxalate nephrolithiasis. Int. Urol. Nephrol. 41, 823-833.
63. Lin K.C., Krieg R.J., Saborio P., Chan J.C. (1998) Increased heat shock protein-70 in unilateral ureteral obstruction in rats. Mol. Genet. Metab. 65, 303-310.
64. Liu Y. (2006) Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int. 69, 213-217.
65. Liu Z.C., Chow K.M., Chang T.M. (2003) Evaluation of two protocols of uremic rat model: partial nephrectomy and infarction. Ren. Fail. 25, 935-943.
66. Liu J.Q., Zelko I.N., Erbynn E.M., Sham J.S., Folz R.J. (2006) Hypoxic pulmonary hypertension: role of superoxide and NADPH oxidase (gp91phox). Am. J. Physiol. Lung Cell. Mol. Physiol. 290, L2-L10.
67. Liu F., Wei C.C., Wu S.J. et al. (2009) Apocynin attenuates tubular apoptosis and tubulointerstitial fibrosis in transgenic mice independent of hypertension. Kidney Int. 75, 156-166.
68. López B., Salom M.G., Arregui B., Valero F., Fenoy F.J. (2003) Role of superoxide in modulating the renal effects of angiotensin II. Hypertension 42, 1150-1156.
69. Ma F.Y., Tesch G.H., Flavell R.A., Davis R.J., Nikolic-Paterson D.J. (2007) MKK3-p38 signaling promotes apoptosis and the early inflammatory response in the obstructed mouse kidney. Am. J. Physiol. Renal Physiol. 293, F1556-F1563.
70. Mackensen-Haen S., Bader R., Grund K.E., Bohle A. (1981) Correlations between renal cortical interstitial fibrosis, atrophy of the proximal tubules and impairment of the glomerular filtration rate. Clin. Nephrol. 15, 167-171.
71. Manucha W., Carrizo L., Ruete C., Molina H., Vallés P. (2005) Angiotensin II type I antagonist on oxidative stress and heat shock protein 70 (HSP 70) expression in obstructive nephropathy. Cell. Mol. Biol. (Noisy-le-grand) 51, 547-555.
72. Miriyala S., Gongora Nieto M.C., Mingone C. et al. (2006) Bone morphogenic protein-4 induces hypertension in mice: role of noggin, vascular NADPH oxidases, and impaired vasorelaxation. Circulation 113, 2818-2825.
73. Miyajima A., Chen J., Poppas D.P., Vaughan E.D. Jr, Felsen D. (2001) Role of nitric oxide in renal tubular apoptosis of unilateral ureteral obstruction. Kidney Int. 59, 1290-1303.
74. Miyazono K., Maeda S., Imamura T. (2005) BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk. Cytokine Growth Factor Rev. 16, 251-263.
75. Mizuguchi Y., Chen J., Seshan S.V., Poppas D.P., Szeto H.H., Felsen D. (2008) A novel cell-permeable antioxidant peptide decreases renal tubular apoptosis and damage in unilateral ureteral obstruction. Am. J. Physiol. Renal Physiol. 295, F1545-F1553.
76. Modlinger P.S., Wilcox C.S., Aslam S. (2004) Nitric oxide, oxidative stress, and progression of chronic renal failure. Semin. Nephrol. 24, 354-365.
77. Moriyama T., Kawada N., Nagatoya K., Horio M., Imai E., Hori M. (2000) Oxidative stress in tubulointerstitial injury: therapeutic potential of antioxidants towards interstitial fibrosis. Nephrol. Dial. Transplant. 15(Suppl 6), 47-49.
78. Moulton P., Martin H., Ainger A. et al. (2000) The inhibition of flavoproteins by phenoxaiodonium, a new iodonium analogue. Eur. J. Pharmacol. 401, 115-120.
79. Muijsers R.B., van Den Worm E., Folkerts G. et al. (2000) Apocynin inhibits peroxynitrite formation by murine macrophages. Br. J. Pharmacol. 130, 932-936.
80. Nagle R.B., Bulger R.E., Cutler R.E., Jervis H.R., Benditt E.P. (1973) Unilateral obstructive nephropathy in the rabbit. I. Early morphologic, physiologic, and histochemical changes. Lab. Invest. 28, 456-467.
81. Nam S.M., Lee M.Y., Koh J.H. et al. (2009) Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property. Diabetes Res. Clin. Pract. 83, 176-182.
82. Nishida M., Okumura Y., Sato H., Hamaoka K. (2008) Delayed inhibition of p38 mitogen-activated protein kinase ameliorates renal fibrosis in obstructive nephropathy. Nephrol. Dial. Transplant. 23, 2520-2524.
83. Oliveira-Sales E.B., Dugaich A.P., Carillo B.A. et al. (2008) Oxidative stress contributes to renovascular hypertension. Am. J. Hypertens. 21, 98-104.
84. Ophascharoensuk V., Giachelli C.M., Gordon K. et al. (1999) Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int. 56, 571-580.
85. Ozbek E., Ilbey Y.O., Ozbek M., Simsek A., Cekmen M., Somay A. (2009) Melatonin attenuates unilateral ureteral obstruction-induced renal injury by reducing oxidative stress, iNOS, MAPK, and NK-kB expression. J. Endourol. 23, 1165-1173.
86. Paravicini T.M., Touyz R.M. (2008) NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care 31(Suppl 2), S170-S180.
87. Pat B., Yang T., Kong C., Watters D., Johnson D.W., Gobe G. (2005) Activation of ERK in renal fibrosis after unilateral ureteral obstruction: modulation by antioxidants. Kidney Int. 67, 931-943.
88. Pollock J.D., Williams D.A., Gifford M.A. et al. (1995) Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat. Genet. 9, 202-209.
89. Prakash J., de Borst M.H., van Loenen-Weemaes A.M. et al. (2008) Cell-specific delivery of a transforming growth factor-beta type I receptor kinase inhibitor to proximal tubular cells for the treatment of renal fibrosis. Pharm. Res. 25, 2427-2439.
90. Rabbani N., Sebekova K., Sebekova K. Jr, Heidland A., Thornalley P.J. (2007) Accumulation of free adduct glycation, oxidation, and nitration products follows acute loss of renal function. Kidney Int. 72, 1113-1121.
91. Riganti C., Costamagna C., Doublier S. et al. (2008) The NADPH oxidase inhibitor apocynin induces nitric oxide synthesis via oxidative stress. Toxicol. Appl. Pharmacol. 228, 277-285.
92. Rouschop K.M., Claessen N., Pals S.T., Weening J.J., Florquin S. (2006) CD44 disruption prevents degeneration of the capillary network in obstructive nephropathy via reduction of TGF-beta1-induced apoptosis. J. Am. Soc. Nephrol. 17, 746-753.
93. Saborio P., Krieg R.J., Kuemmerle N.B., Norkus E.P., Schwartz C.C., Chan J.C. (2000) Alpha-tocopherol modulates lipoprotein cytotoxicity in obstructive nephropathy. Pediatr. Nephrol. 14, 740-746.
94. Salguero G., Akin E., Templin C. et al. (2008) Renovascular hypertension by two-kidney one-clip enhances endothelial progenitor cell mobilization in a p47phox-dependent manner. J. Hypertens. 26, 257-268.
95. Sato M., Muragaki Y., Saika S., Roberts A.B., Ooshima A. (2003) Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J. Clin. Invest. 112, 1486-1494.
96. Satoh M., Kashihara N., Yamasaki Y. et al. (2001) Renal interstitial fibrosis is reduced in angiotensin II type 1a receptor-deficient mice. J. Am. Soc. Nephrol. 12, 317-325.
97. Satoh M., Fujimoto S., Haruna Y. et al. (2005) NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. Am. J. Physiol. Renal. Physiol. 288, F1144-F1152.
98. Schiller M., Javelaud D., Mauviel A. (2004) TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing. J. Dermatol. Sci. 35, 83-92.
99. Schreiner G., Harris K.P., Purkerson M.L., Klahr S. (1988) Immunological aspects of acute ureteral obstruction: immune cell infiltrate in the kidney. Kidney Int. 34, 487-493.
100. Sharma A.K., Mauer S.M., Kim Y., Michael A.F. (1993) Interstitial fibrosis in obstructive nephropathy. Kidney Int. 44, 774-788.
101. Shi X.Y., Hou F.F., Niu H.X. et al. (2008) Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal nicotinamide adenine dinucleotide phosphate oxidase. Endocrinology 149, 1829-1839.
102. Shin G.T., Kim W.H., Yim H., Kim M.S., Kim H. (2005) Effects of suppressing intrarenal angiotensinogen on renal transforming growth factor-beta1 expression in acute ureteral obstruction. Kidney Int. 67, 897-908.
103. Stambe C., Atkins R.C., Tesch G.H., Masaki T., Schreiner G.F., Nikolic-Paterson D.J. (2004) The role of p38alpha mitogen-activated protein kinase activation in renal fibrosis. J. Am. Soc. Nephrol. 15, 370-379.
104. Stolk J., Hiltermann T.J., Dijkman J.H., Verhoeven A.J. (1994) Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. Am. J. Respir. Cell Mol. Biol. 11, 95-102.
105. Sugiyama H., Kobayashi M., Wang D.H. et al. (2005) Telmisartan inhibits both oxidative stress and renal fibrosis after unilateral ureteral obstruction in acatalasemic mice. Nephrol. Dial. Transplant. 20, 2670-2680.
106. Sunami R., Sugiyama H., Wang D.H. et al. (2004) Acatalasemia sensitizes renal tubular epithelial cells to apoptosis and exacerbates renal fibrosis after unilateral ureteral obstruction. Am. J. Physiol. Renal. Physiol. 286, F1030-F1038.
107. Taneda S., Hudkins K., Topouzis S. et al. (2003) Obstructive uropathy in mice and humans: potential role for PDGF-D in the progression of tubulointerstitial injury. J. Am. Soc. Nephrol. 14, 2544-2555.
108. Taylor N.E., Glocka P., Liang M., Cowley A.W. (2006) NADPH oxidase in the renal medulla causes oxidative stress and contributes to salt-sensitive hypertension in Dahl S rats. Hypertension 47, 692-698.
109. Thallas-Bonke V., Thorpe S.R., Coughlan M.T. et al. (2008) Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway. Diabetes 57, 460-469.
110. Tian N., Moore R.S., Phillips W.E. et al. (2008) NADPH oxidase contributes to renal damage and dysfunction in Dahl salt-sensitive hypertension. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295, R1858-R1865.
111. Tornavaca O., Pascual G., Barreiro M.L. et al. (2009) Kidney androgen-regulated protein transgenic mice show hypertension and renal alterations mediated by oxidative stress. Circulation 119, 1908-1917.
112. Truong L., Choi Y.J., Tsao C.C. et al. (2001) Renal cell apoptosis in chronic obstructive uropathy: the roles of caspases. Kidney Int. 60, 924-934.
113. Vaughan E.D. Jr, Marion D., Poppas D.P., Felsen D. (2004) Pathophysiology of unilateral ureteral obstruction: studies from Charlottesville to New York. J. Urol. 172, 2563-2569.
114. Vaziri N.D., Dicus M., Ho N.D., Boroujerdi-Rad L., Sindhu R.K. (2003) Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency. Kidney Int. 63, 179-185.
115. Vieira J.M., Mantovani E., Rodrigues L.T. et al. (2005) Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction. Nephrol. Dial. Transplant. 20, 1582-1591.
116. Vielhauer V., Anders H.J., Mack M. et al. (2001) Obstructive nephropathy in the mouse: progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2- and 5-positive leukocytes. J. Am. Soc. Nephrol. 12, 1173-1187.
117. Wang Y., Sun Z. (2009) Klotho gene delivery prevents the progression of spontaneous hypertension and renal damage. Hypertension 54, 810-817.
118. Wang L., Lee J.Y., Kwak J.H., He Y., Kim S.I., Choi M.E. (2008) Protective effects of low-dose carbon monoxide against renal fibrosis induced by unilateral ureteral obstruction. Am. J. Physiol. Renal Physiol. 294, F508-F517.
119. Wang Z., Wei X., Zhang Y. et al. (2009) NADPH oxidase-derived ROS contributes to upregulation of TRPC6 expression in puromycin aminonucleoside-induced podocyte injury. Cell Physiol. Biochem. 24, 619-626.
120. Wolak T., Kim H., Ren Y., Kim J., Vaziri N.D., Nicholas S.B. (2009) Osteopontin modulates angiotensin II-induced inflammation, oxidative stress, and fibrosis of the kidney. Kidney Int. 76, 32-43.
121. Xia Z., Abe K., Furusu A. et al. (2008) Suppression of renal tubulointerstitial fibrosis by small interfering RNA targeting heat shock protein 47. Am. J. Nephrol. 28, 34-46.
122. Xie P., Sun L., Nayak B. et al. (2009) C/EBP-beta modulates transcription of tubulointerstitial nephritis antigen in obstructive uropathy. J. Am. Soc. Nephrol. 20, 807-819.
123. Yang Z., Asico L.D., Yu P. et al. (2006) D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. Am. J. Physiol. Regul. Integr. Comp. Physiol. 290, R96-R104.
124. Yang J., Lane P.H., Pollock J.S., Carmines P.K. (2010) Protein kinase C-dependent NAD(P)H oxidase activation induced by type 1 diabetes in renal medullary thick ascending limb. Hypertension 55, 468-473.
125. Yi F., Zhang A.Y., Li N. et al. (2006) Inhibition of ceramide-redox signaling pathway blocks glomerular injury in hyperhomocysteinemic rats. Kidney Int. 70, 88-96.
126. Yogi A., Mercure C., Touyz J. et al. (2008) Renal redox-sensitive signaling, but not blood pressure, is attenuated by Nox1 knockout in angiotensin II-dependent chronic hypertension. Hypertension 51, 500-506.
127. Yokoi H., Mukoyama M., Nagae T. et al. (2004) Reduction in connective tissue growth factor by antisense treatment ameliorates renal tubulointerstitial fibrosis. J. Am. Soc. Nephrol. 15, 1430-1440.
128. Zeisberg M. (2006) Bone morphogenic protein-7 and the kidney: current concepts and open questions. Nephrol. Dial. Transplant. 21, 568-573.
129. Zhang Y. (2009) Non-Smad pathways in TGF-beta signaling. Cell Res. 19, 128-139.
130. Zhang Y., Chan M.M., Andrews M.C. et al. (2005) Apocynin but not allopurinol prevents and reverses adrenocorticotropic hormone-induced hypertension in the rat. Am. J. Hypertens. 18, 910-916.
131. Zhou M.S., Schuman I.H., Jaimes E.A., Raij L. (2008) Renoprotection by statins is linked to a decrease in renal oxidative stress, TGF-beta, and fibronectin with concomitant increase in nitric oxide bioavailability. Am. J. Physiol. Renal. Physiol. 295, F53-F59.
132. Zwijsen A., Verschueren K., Huylebroeck D. (2003) New intracellular components of bone morphogenetic protein/Smad signaling cascades. FEBS Lett. 546, 133-139.